Literature DB >> 9090368

Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9090368     DOI： 10.1176/ajp.154.4.1

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  85 in total

Review 1.  Fortnightly review. Treatment of schizophrenia.

Authors:  J McGrath; W B Emmerson
Journal:  BMJ       Date:  1999-10-16

2.  Identifying clinical competencies that support rehabilitation and empowerment in individuals with severe mental illness.

Authors:  A S Young; S L Forquer; A Tran; M Starzynski; J Shatkin
Journal:  J Behav Health Serv Res       Date:  2000-08       Impact factor: 1.505

Review 3.  Psychosocial treatments for schizophrenia.

Authors:  A S Bellack; S A Brown
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

Review 4.  Choosing the right dose of antipsychotics in schizophrenia: lessons from neuroimaging studies.

Authors:  J Tauscher; S Kapur
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

5.  Toward a national consumer survey: evaluation of the CABHS and MHSIP instruments.

Authors:  S V Eisen; J A Shaul; H S Leff; V Stringfellow; B R Clarridge; P D Cleary
Journal:  J Behav Health Serv Res       Date:  2001-08       Impact factor: 1.505

6.  A comparison of correlates of suicidal ideation prior to initial hospitalization for first-episode psychosis with prior research on correlates of suicide attempts prior to initial treatment seeking.

Authors:  Peggy Flanagan; Michael T Compton
Journal:  Early Interv Psychiatry       Date:  2011-12-13       Impact factor: 2.732

7.  A study of treatment outcomes from atypical antipsychotic medications in the Virginia public system of community care.

Authors:  David M Ziegler; Thomas J Peachey
Journal:  Community Ment Health J       Date:  2003-04

8.  Serum ghrelin concentrations in patients receiving olanzapine or risperidone.

Authors:  Takashi Togo; Koichi Hasegawa; Satoshi Miura; Hideki Hosojima; Katsuo Kojima; Mika Shoji; Akihiko Kase; Hirotake Uchikado; Eizo Iseki; Kenji Kosaka
Journal:  Psychopharmacology (Berl)       Date:  2003-10-09       Impact factor: 4.530

9.  Association Between Process-Based Quality Indicators and Mortality for Patients With Substance Use Disorders.

Authors:  Susan M Paddock; Kimberly A Hepner; Teresa Hudson; Songthip Ounpraseuth; Amy M Schrader; Greer Sullivan; Katherine E Watkins
Journal:  J Stud Alcohol Drugs       Date:  2017-05       Impact factor: 2.582

10.  Caregivers' stresses when living together or apart from patients with chronic schizophrenia.

Authors:  Tannis M Laidlaw; John H Coverdale; Ian R H Falloon; Robert R Kydd
Journal:  Community Ment Health J       Date:  2002-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.